CUBT.US Curative Biotechnology Inc

Healthcare Biotechnology USA Stocks
0.8052 USD
Close of Nov 13, 2026
0.4500 1.99
Market cap
USD 7.16M
P/E
-
P/B
-
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is CUBT.US undervalued?

Graham number

The Graham number of Curative Biotechnology Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Curative Biotechnology Inc fundamental analysis

No fundamental analysis for Curative Biotechnology Inc yet.

Curative Biotechnology Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Curative Biotechnology Inc

Curative Biotechnology, Inc., a biopharmaceutical company, focuses on identifying, in licensing, and developing therapeutic drug candidates for rare disease indications. It develops Metformin Reformulation to treat intermediate dry macular degeneration and geographic atrophy; IMT504, a novel immunotherapy to treat late-stage rabies; and CUBT906, a fully humanized CD56 monoclonal antibody carrying a cytotoxic drug conjugate directly to the tumor site to kill the tumor by inhi…

Full company profile